Mechanisms of Immunosuppression in Colorectal Cancer
CRC is the third most diagnosed cancer in the US with the second-highest mortality rate. A multi-modality approach with surgery/chemotherapy is used in patients with early stages of colon cancer. Radiation therapy is added to the armamentarium in patients with locally advanced rectal cancer. While s...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/12/3850 |
id |
doaj-2422c74580fe409ca6c793198c3b53b0 |
---|---|
record_format |
Article |
spelling |
doaj-2422c74580fe409ca6c793198c3b53b02020-12-21T00:01:13ZengMDPI AGCancers2072-66942020-12-01123850385010.3390/cancers12123850Mechanisms of Immunosuppression in Colorectal CancerYang Zhang0Ashwani Rajput1Ning Jin2Jing Wang3Department of Cancer Biology and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USAJohns Hopkins Sidney Kimmel Cancer Center, National Capital Region, Sibley Memorial Hospital, 5255 Loughboro Road NW, Washington, DC 20016, USADivision of Medical Oncology, Department of Internal Medicine, James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USADepartment of Cancer Biology and Genetics, James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USACRC is the third most diagnosed cancer in the US with the second-highest mortality rate. A multi-modality approach with surgery/chemotherapy is used in patients with early stages of colon cancer. Radiation therapy is added to the armamentarium in patients with locally advanced rectal cancer. While some patients with metastatic CRC are cured, the majority remain incurable and receive palliative chemotherapy as the standard of care. Recently, immune checkpoint blockade has emerged as a promising treatment for many solid tumors, including CRC with microsatellite instability. However, it has not been effective for microsatellite stable CRC. Here, main mechanisms of immunosuppression in CRC will be discussed, aiming to provide some insights for restoring immunosurveillance to improve treatment efficacy in CRC.https://www.mdpi.com/2072-6694/12/12/3850colorectal cancerimmunosuppressionimmunotherapymicrosatellite stablecell surface proteincytokine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yang Zhang Ashwani Rajput Ning Jin Jing Wang |
spellingShingle |
Yang Zhang Ashwani Rajput Ning Jin Jing Wang Mechanisms of Immunosuppression in Colorectal Cancer Cancers colorectal cancer immunosuppression immunotherapy microsatellite stable cell surface protein cytokine |
author_facet |
Yang Zhang Ashwani Rajput Ning Jin Jing Wang |
author_sort |
Yang Zhang |
title |
Mechanisms of Immunosuppression in Colorectal Cancer |
title_short |
Mechanisms of Immunosuppression in Colorectal Cancer |
title_full |
Mechanisms of Immunosuppression in Colorectal Cancer |
title_fullStr |
Mechanisms of Immunosuppression in Colorectal Cancer |
title_full_unstemmed |
Mechanisms of Immunosuppression in Colorectal Cancer |
title_sort |
mechanisms of immunosuppression in colorectal cancer |
publisher |
MDPI AG |
series |
Cancers |
issn |
2072-6694 |
publishDate |
2020-12-01 |
description |
CRC is the third most diagnosed cancer in the US with the second-highest mortality rate. A multi-modality approach with surgery/chemotherapy is used in patients with early stages of colon cancer. Radiation therapy is added to the armamentarium in patients with locally advanced rectal cancer. While some patients with metastatic CRC are cured, the majority remain incurable and receive palliative chemotherapy as the standard of care. Recently, immune checkpoint blockade has emerged as a promising treatment for many solid tumors, including CRC with microsatellite instability. However, it has not been effective for microsatellite stable CRC. Here, main mechanisms of immunosuppression in CRC will be discussed, aiming to provide some insights for restoring immunosurveillance to improve treatment efficacy in CRC. |
topic |
colorectal cancer immunosuppression immunotherapy microsatellite stable cell surface protein cytokine |
url |
https://www.mdpi.com/2072-6694/12/12/3850 |
work_keys_str_mv |
AT yangzhang mechanismsofimmunosuppressionincolorectalcancer AT ashwanirajput mechanismsofimmunosuppressionincolorectalcancer AT ningjin mechanismsofimmunosuppressionincolorectalcancer AT jingwang mechanismsofimmunosuppressionincolorectalcancer |
_version_ |
1724375999253053440 |